IP Library Granted Patent US 11,302,433
Granted Patent B2
US 11,302,433 · App. 16/394,751 · Granted Apr 12, 2022

Diabetes therapy coaching

Inventors: Michael L. Blomquist (Blaine, MN); Kevin Kopp (St. Paul, MN); Thomas Alan Savard (Arden Hills, MN)
Assignee: Tandem Diabetes Care, Inc.
G16H20/17A61B5/14532A61B5/4836A61B5/746A61M5/142A61M5/14244A61M5/1723G16H70/20G16Z99/00A61M2005/14208A61M2202/0007A61M2205/3327A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,302,433
App. No.
16/394,751
Granted
Apr 12, 2022
Kind
B2
Abstract

An apparatus comprising a pump, an input configured to receive information related to a user, a user interface, and a controller communicatively coupled to the pump, the input, and the user interface. The controller includes a timing module configured to initiate delivery of a drug in time and to adjust delivery according to the received information. Other devices, systems, and methods are disclosed.

Claims (34)

1. A method of providing diabetes therapy, comprising:

receiving information relating to glucose levels of a user from a continuous glucose monitoring device;

evaluating a user's management of the user's glucose levels based on the information relating to glucose levels;

determining one or more past user practices that could be modified to improve the user's management of the user's glucose levels based on the evaluation; and

providing a message to the user with advice as to how the user can modify the one or more past user practices to improve the user's management of the user's glucose levels.

2. The method of claim 1 , wherein the one or more past user practices include one or more dietary habits of the user.

3. The method of claim 1 , wherein the one or more past user practices include a user's behavior in using insulin to manage the user's glucose levels.

4. The method of claim 3 , wherein the user's behavior in using insulin to manage the user's glucose levels includes the user's use of an insulin pump.

5. The method of claim 1 , wherein the evaluating the user's management of the user's glucose levels includes evaluating on or more tendencies of the user's glucose levels.

6. The method of claim 1 , wherein the evaluating the user's management of the user's glucose levels includes evaluating the user's glucose levels with respect to one or more target glucose levels.

7. The method of claim 1 , wherein the providing the message to the user with advice as to how the user can modify the one or more past user practices to improve the user's management of the user's glucose levels includes providing the message on a display of a blood glucose management device.

8. The method of claim 7 , wherein the blood glucose management device is an insulin pump.

9. The method of claim 7 , wherein the blood glucose management device is a computing device.

10. The method of claim 1 , wherein evaluating the user's management of the user's glucose levels based on the information relating to glucose levels includes comparing the user's management of the user's glucose levels to guideline parameters for management of glucose levels.

11. A method of providing diabetes therapy, comprising:

receiving information relating to glucose levels of a user from a continuous glucose monitoring device;

receiving information relating to meals consumed by the user;

evaluating a user's management of the user's glucose levels based on the information relating to glucose levels and the information relating to meals consumed by the user;

determining one or more dietary habits of the user that could be modified to improve the user's management of the user's glucose levels based on the evaluation; and

providing a message to the user regarding the one or more dietary habits.

12. The method of claim 11 , wherein providing a message to the user regarding the one or more dietary habits includes providing advice to the user on how to improve management of the user's glucose levels based on the one or more dietary habits.

13. The method of claim 11 , wherein providing the message to the user regarding the one or more dietary habits includes providing the message on a display of a blood glucose management device.

14. The method of claim 13 , wherein the blood glucose management device is an insulin pump.

15. The method of claim 13 , wherein the blood glucose management device is a computing device.

16. A method of providing diabetes therapy, comprising:

receiving information relating to glucose levels of a user from a continuous glucose monitoring device;

receiving information relating to a user's behavior in using insulin to manage the user's glucose levels;

evaluating a user's management of the user's glucose levels based on the information relating to glucose levels and the information relating to the user's behavior in using insulin to manage the user's glucose levels;

determining how the user's behavior in using insulin to manage the user's glucose levels could be modified to improve the user's management of the user's glucose levels based on the evaluation; and

providing a message to the user regarding modification of the user's behavior in using insulin to manage the user's glucose levels.

17. The method of claim 16 , wherein the user's behavior in using insulin to manage the user's glucose levels includes the user's use of an insulin pump.

18. The method of claim 16 , wherein evaluating the user's management of the user's glucose levels includes evaluating one or more tendencies of the user's glucose levels.

19. The method of claim 16 , wherein evaluating the user's management of the user's glucose levels includes evaluating the user's glucose levels with respect to one or more target glucose levels.

20. The method of claim 16 , wherein providing the message to the user regarding the user's behavior in using insulin to manage the user's glucose levels includes providing the message on a display of a blood glucose management device.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2024
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: TANDEM DIABETES CARE, INC.
Reel/Frame 066880/0918 →
SECURITY INTEREST Recorded May 25, 2022
From: TANDEM DIABETES CARE, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 060179/0100 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2019
From: SMITHS MEDICAL ASD, INC.
To: TANDEM DIABETES CARE, INC.
Reel/Frame 050059/0348 →
MERGER Recorded Aug 13, 2019
From: SMITHS MEDICAL MD, INC.
To: SMITHS MEDICAL ASD, INC.
Reel/Frame 050039/0581 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2019
From: BLOMQUIST, MICHAEL; KOPP, KEVIN; SAVARD, THOMAS A.
To: SMITHS MEDICAL MD, INC.
Reel/Frame 050003/0603 →
Continuity (5)
Continuation 14797652 · Jul 13, 2015
Continuation 14455508 · Aug 8, 2014
Continuation 12908218 · Oct 20, 2010
Division 11970232 · Jan 7, 2008
Related Publication 20190350501A1 · Nov 21, 2019
Cited By (1)
US 12,431,104